The mRNA levels of BICC1 were increased in 10 cancers, such as pancreatic adenocarcinoma, glioblastoma multiforme, glioma, stomach adenocarcinoma, kidney renal papillary cell carcinoma, and cholangiocarcinoma. Here, BICC1 is linked to cholangiocarcinoma.